PlanAct: An eclipse scripting API-based module embedding clinical optimization strategies for automated planning in locally advanced non-small cell lung cancer.
Hao Guo, Tenzin Kunkyab, Yang Lei, Kenneth Rosenzweig, Robert Samstein, Ming Chao, Tian Liu, Junyi Xia, Jiahan Zhang
Abstract
Open AccessBACKGROUND: Manual intensity-modulated radiotherapy (IMRT) planning for locally advanced non-small cell lung cancer (LA-NSCLC) is labor-intensive and time-consuming. Knowledge-based planning (e.g., RapidPlan) improves consistency but commonly falls short in fully meeting clinical objectives in LA-NSCLC cases, requiring iterative manual adjustments. PURPOSE: To develop and validate PlanAct, an Eclipse Scripting API (ESAPI)-based module for optimizing automated IMRT planning in LA-NSCLC, and to compare its performance against clinical and RapidPlan-generated plans across a retrospective patient cohort. METHODS: PlanAct was developed with modular functions to automate key tasks in IMRT plan generation and optimization. PlanAct was manually executed on 56 anonymized retrospective LA-NSCLC cases using a standardized nine-beam geometry. Plans were normalized to ensure 95% planning target volume (PTV) coverage. The PlanAct-optimized plans were evaluated against RapidPlan-generated plans and clinically approved plans using institutional plan quality metrics, including dose-volume constraints for the esophagus, spinal cord, lungs, heart, larynx, and PTV. Statistical comparisons were performed to assess differences in plan quality and unmet dosimetric requirements. RESULTS: PlanAct-optimized plans demonstrated significant improvement in plan quality compared to RapidPlan, with fewer unmet clinical requirements and better organ-at-risk sparing, particularly for the lungs (p < 0.001 for V20 and Dmean). Only one PlanAct-optimized plan failed to meet all dose constraints (in this case, lungs Dmean) due to a large PTV volume, compared to 18 RapidPlan and 10 clinical plans. Even in anatomically challenging cases, PlanAct produced more favorable dose distributions, with superior hotspot control. CONCLUSIONS: PlanAct is an effective tool to optimize automated IMRT planning in LA-NSCLC. It produced plans comparable to or better than clinical plans, even in challenging cases. Its modular architecture makes it promising for integration into future fully autonomous, patient-specific radiotherapy treatment planning systems.